| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Nov 29, 2023 |
|||||||||
| Q3 FY24 | $2.11 | $2.06 | $8.72B | $8.72B |
NYSE |
||||
| Q3 FY23 | $1.02 | $1.01 | $7.31B | $7.40B |
NASDAQ |
||||
|
Hormel Foods
HRL
|
Q4 FY23 | $0.42 | $0.44 | $3.20B | $3.26B |
NYSE |
|||
|
PVH
PVH
|
- | $2.90 | $2.74 | $2.36B | $2.41B |
NYSE |
|||
|
Foot Locker
FL
|
Q3 FY23 | $0.30 | $0.21 | $1.99B | $2.26B |
NYSE |
|||
|
Victoria's Secret
VSCO
|
- | -$0.86 | -$0.80 | $1.27B | $2.09B |
NYSE |
|||
|
Patterson Companies
PDCO
|
Q2 FY24 | $0.50 | $0.58 | $1.65B | $1.70B |
NASDAQ |
|||
|
Petco Health and Wellness Company
WOOF
|
Q3 FY23 | -$0.05 | -$0.01 | $1.49B | $1.62B |
NASDAQ |
|||
|
Ingles Markets
IMKTA
|
- | $2.77 | - | $1.58B | - |
NASDAQ |
|||
| Q4 FY23 | $3.17 | $3.04 | $1.60B | $1.58B |
NASDAQ |
||||
|
Donaldson
DCI
|
Q1 FY24 | $0.75 | $0.72 | $846.30M | $854.56M |
NYSE |
|||
| Q3 FY24 | $0.50 | $0.41 | $762.84M | $763.36M |
NYSE |
||||
|
Five Below
FIVE
|
Q3 FY23 | $0.26 | $0.24 | $736.41M | $737.64M |
NASDAQ |
|||
|
Vestis
VSTS
|
Q4 FY23 | $1.22 | $0.32 | $715.90M | $713.58M |
NYSE |
|||
| Q3 FY24 | $0.25 | $0.15 | $734.17M | $713.06M |
NYSE |
||||
| Q3 FY24 | $0.44 | $0.30 | $584M | $563.14M |
NASDAQ |
||||
| Q1 FY24 | $0.29 | $0.17 | $511.05M | $545.49M |
NASDAQ |
||||
|
La-Z-Boy
LZB
|
- | $0.74 | $0.62 | $511.44M | $502.33M |
NYSE |
|||
|
Construction Partners
ROAD
|
Q4 FY23 | $0.59 | $0.52 | $475.03M | $464.71M |
NASDAQ |
|||
|
nCino
NCNO
|
Q3 FY24 | $0.14 | $0.11 | $121.94M | $124.62M |
NASDAQ |
|||
|
Zuora
ZUO
|
Q3 FY24 | $0.09 | $0.06 | $109.85M | $110.79M |
NYSE |
|||
|
Arrowhead Pharmaceuticals
ARWR
|
Q4 FY23 | -$1.03 | -$0.70 | $16.10M | $50.73M |
NASDAQ |
|||
|
Credo Technology Group Holding Ltd
CRDO
|
Q2 FY24 | $0.01 | - | $44.04M | $42.70M |
NASDAQ |
|||
|
ArrowMark Financial
BANX
|
- | $0.46 | - | - | $6.45M |
NASDAQ |
|||
| Show 14 more companies | |||||||||